Patents Assigned to ShanghaiFosunPharmaceuticalIndustrialDevelopmentCo.,
  • Publication number: 20220144806
    Abstract: Disclosed is a PD-L1 inhibitor, and specifically disclosed is a compound of formula (I) as a PD-L1 immunomodulator, a pharmaceutically acceptable salt or an isomer thereof.
    Type: Application
    Filed: February 3, 2020
    Publication date: May 12, 2022
    Applicant: ShanghaiFosunPharmaceuticalIndustrialDevelopmentCo.,
    Inventors: Yang Zhang, Yuanfeng Xia, Zhengxia Chen, Meibi Dai, Deheng Sun, Jian Zuo, Jian Li, Shuhui Chen
  • Publication number: 20220119368
    Abstract: The present invention relates to a PD-L1 immunomodulator, and specifically discloses a compound of formula (I) as a PD-L1 immunomodulator, a pharmaceutically acceptable salt or an isomer thereof.
    Type: Application
    Filed: February 3, 2020
    Publication date: April 21, 2022
    Applicant: ShanghaiFosunPharmaceuticalIndustrialDevelopmentCo.,Ltd
    Inventors: Yang Zhang, Yuanfeng Xia, Deheng Sun, Jian Zuo, Zhengxia Chen, Meibi Dai, Jian Li, Shuhui Chen